aTYR PHARMA INC (ATYR): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

92.99M
Year ended 2025-12-31
+48.5%
3-year compound annual growth
2020-12-31: 9.16M2021-12-31: 19.08M2022-12-31: 28.42M2023-12-31: 53.61M2024-12-31: 74.26M2025-12-31: 92.99M92.99M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3192.99M+25.2%2026-03-05, From 2025-01-01
2024-12-3174.26M+38.5%2026-03-05, From 2024-01-01
2023-12-3153.61M+88.6%2026-03-05, From 2023-01-01
2022-12-3128.42Mn/c2025-03-13, From 2022-01-01
2021-12-3119.08Mn/c2024-03-14, From 2021-01-01
2020-12-319.16Mn/a2023-03-14, From 2020-01-01